Skip to main content

Advertisement

Table 3 Clinico-pathologic characteristics of 101 EOC patients and their association with LipB mRNA expression

From: Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis

Parameters Fold change 95%CI p-value
Histological type    
Serous vs endometrioid 0.84 0.25-2.22 0.773
Serous vs clear cell 3.43 0.002-0.79 0.027
Serous vs mucinous 1756 0.66-3.83 0.345
Serous vs mixed 1.05 0.51-2.34 0.533
Serous vs undifferentiated 12.99 1.80-7.88 0.007
Endometrioid vs clear cell 4.04 0.66-2.83 0.265
Endometrioid vs mucinous 2069 0.46-3.73 0.487
Endometrioid vs mixed 1.24 0.27-2.32 0.765
Endometrioid vs undifferentiated 15.31 0.96-1.73 0.094
Clear cell vs mucinous 511 0.36-3.52 0.446
Clear cell vs undifferentiated 3.78 0.46-2.94 0.269
Mixed vs clear cell 3.25 0.71-3.72 0.151
Mixed vs mucinous 1660 0.36-3.54 0.412
Mixed vs undifferentiated 12.28 0.007-0.89 0.036
Undifferentiated vs mucinous 135 0.22-3.77 0.990
Histological grade    
G2 + G3 vs G1 0.04 0.003-0.59 0.02
FIGO stage    
III + IV vs I + II 0.80 0.29-2.14 0.66
Age at diagnosis (y)    
>60 vs ≤60 1.09 0.512-2.335 0.58
Residual tumor (RT), cm    
RT > 0 vs RT = 0 0.99 0.41-2.38 0.99
Presence of ascites    
yes vs no 1.69 0.76-3.73 0.19
Lymph node involvement    
positive vs negative 1.03 0.42-2.52 0.94